Anti-Chromogranin A antibody,Abcam,AB15160

Product Specifications Anti-Chromogranin A antibody (ab15160) is a rabbit polyclonal antibody and is validated for use in IHC-P in human samples. Anti-Chromogranin A antibody (ab15160) specifically detects Chromogranin A (UniProt ID: P10645; Molecular weight: 49kDa) and is sold in 100 µL, 500 µL and 1 mL selling sizes. Quality and Validation Abcam's high quality validation processes ensure Anti-Chromogranin A antibody (ab15160) has high sensitivity and specificity. Anti-Chromogranin A antibody (ab15160) has been cited over 238 times in peer reviewed journals and is trusted by the scientific community. Anti-Chromogranin A antibody (ab15160) has 29 independent reviews from customers. Target Information Chromogranin A (CgA) or parathyroid secretory protein 1 is encoded in the human by the gene CHGA. Chromogranin A (CgA) is found in the secretory vesicles of neuroendocrine cells and serves as a key biomarker in oncology. It is particularly useful in diagnosing and monitoring neuroendocrine tumors (NETs).

Host

Rabbit

Reactivity

Human

Application

IHC-P

Platform ID

BAB324699685

Abcam

Headquarters

Discovery Drive Cambridge Biomedical Campus Cambridge CB2 0AX UK

Contact

Tel: +44 (0)1223 696000
Fax: +44 (0)1223 215 215

Product Specifications
Scientific Background

Specifications

NameAnti-Chromogranin A antibody
Cat. No.AB15160
HostRabbit
IsotypeIgG
ReactivityHuman
ApplicationIHC-P
ClonalityPolyclonal
Concentration0.175 mg/mL Batch dependent concentration
ImmunogenThe exact immunogen used to generate this antibody is proprietary information.
PurityAffinity purification Immunogen
Appearance/FormLiquid
ShippingBlue Ice
FormulationpH: 7.6 Preservative: 0.1% Sodium azide Constituents: PBS, 1% BSA
Storage-20°C
Regulatory StatusResearch Use Only

Scientific Background

Target data Pancreastatin. Strongly inhibits glucose induced insulin release from the pancreas.. Catestatin. Inhibits catecholamine release from chromaffin cells and noradrenergic neurons by acting as a non-competitive nicotinic cholinergic antagonist (PubMed : 15326220). Displays antibacterial activity against Gram-positive bacteria S.aureus and M.luteus, and Gram-negative bacteria E.coli and P.aeruginosa (PubMed : 15723172, PubMed : 24723458). Can induce mast cell migration, degranulation and production of cytokines and chemokines (PubMed : 21214543). Acts as a potent scavenger of free radicals in vitro (PubMed : 24723458). May play a role in the regulation of cardiac function and blood pressure (PubMed : 18541522).. Serpinin. Regulates granule biogenesis in endocrine cells by up-regulating the transcription of protease nexin 1 (SERPINE2) via a cAMP-PKA-SP1 pathway. This leads to inhibition of granule protein degradation in the Golgi complex which in turn promotes granule formation. See full target information CHGA

Category Paths

Request a product

Please provide the required information below so that we can quickly source your products.